Stock Movers: Applied Materials, WBD, Merck (Podcast)

Applied Materials (AMAT) shares declined after reporting a sales drop and forecasting further contraction in the current quarter, despite slightly exceeding Q1 estimates, though the company projects demand recovery by late 2026. Conversely, Warner Bros. Discovery (WBD) stock rose on reports of potential acquisition bids from Paramount, Comcast, and Netflix, as the company considers strategic options and amended CEO David Zaslav's contract to secure stock options in a sale. Merck (MRK) shares moved lower amid news of its impending acquisition of Cidara Therapeutics Inc. at a premium to its $3.3 billion valuation, indicating significant M&A activity in the biotech space.

Analysis

Applied Materials (AMAT) experienced a premarket share decline following a reported sales decrease last quarter and a forecast for a further >4% year-over-year drop to approximately $6.85 billion in fiscal Q1, despite slightly exceeding the $6.81 billion average estimate. This near-term weakness in chip-equipment demand is notable, with the company projecting a significant demand improvement only in the second half of 2026, indicating a prolonged recovery period for the sector.

Warner Bros. Discovery (WBD) shares gained premarket on reports that Paramount, Comcast, and Netflix are preparing acquisition bids, aligning with WBD's recent consideration of strategic options including a sale. The amendment to CEO David Zaslav's contract, ensuring stock option vesting upon a sale, signals internal preparation for a potential transaction and addresses executive incentives.

Merck (MRK) shares dipped premarket amid news of its impending acquisition of Cidara Therapeutics Inc. (CDTX), a biotech firm focused on influenza treatment. The reported deal values Cidara at a premium to its current $3.3 billion valuation, highlighting Merck's strategic expansion in the biotech space and underscoring ongoing consolidation within the pharmaceutical and biotech sectors.

Key Decisions for Investors

• Investors should assess Applied Materials' (AMAT) current valuation against the delayed demand recovery projected for H2 2026, considering potential for further near-term volatility.
• Monitor developments regarding potential acquisition bids for Warner Bros. Discovery (WBD), as a competitive process could unlock significant shareholder value, while also evaluating the implications of CEO contract amendments on governance.
• For Merck (MRK), evaluate the strategic rationale and financial impact of the Cidara acquisition, particularly the premium paid, on its balance sheet and future growth prospects, and for Cidara (CDTX) holders, consider the implied premium and potential for deal completion.